IN182555B - - Google Patents

Info

Publication number
IN182555B
IN182555B IN347MA1996A IN182555B IN 182555 B IN182555 B IN 182555B IN 347MA1996 A IN347MA1996 A IN 347MA1996A IN 182555 B IN182555 B IN 182555B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Bobby W Sandage Jr
Marc Fisher
Kenneth W Locke
Original Assignee
Interneuron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23578854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN182555(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Interneuron Pharma filed Critical Interneuron Pharma
Publication of IN182555B publication Critical patent/IN182555B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN347MA1996 1995-03-06 1996-03-06 IN182555B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39926295A 1995-03-06 1995-03-06

Publications (1)

Publication Number Publication Date
IN182555B true IN182555B (en:Method) 1999-05-01

Family

ID=23578854

Family Applications (1)

Application Number Title Priority Date Filing Date
IN347MA1996 IN182555B (en:Method) 1995-03-06 1996-03-06

Country Status (5)

Country Link
US (2) US5872108A (en:Method)
KR (1) KR19980702724A (en:Method)
IL (1) IL147477A (en:Method)
IN (1) IN182555B (en:Method)
ZA (1) ZA961791B (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6732369B1 (en) * 1995-10-02 2004-05-04 Starsight Telecast, Inc. Systems and methods for contextually linking television program information
HUP0101235A3 (en) * 1997-12-24 2002-04-29 Ferrer Int Hyperhydrated citicoline, process for preparing it and use
US6379882B1 (en) * 1998-09-14 2002-04-30 Elan Pharmaceuticals, Inc. Method for selecting compounds for treating ischemia-related cellular damage
ES2169986B1 (es) 2000-03-14 2003-06-16 Ferrer Int Uso de cdp-colina para el tratamiento profilactico de la isquemia cerebral.
US7235649B2 (en) * 2000-03-24 2007-06-26 Duke University Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
AU2001247759A1 (en) * 2000-03-24 2001-10-08 Duke University Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
US7034054B2 (en) * 2000-12-15 2006-04-25 Galileo Pharmaceuticals, Inc. Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
WO2003100570A2 (en) * 2002-05-23 2003-12-04 New England Medical Center Hospitals, Inc. Computer-assisted multi-dimensional patient selection
US9572830B2 (en) * 2004-05-13 2017-02-21 Massachusetts Institute Of Technology Uridine effects on dopamine release
MX2007015006A (es) 2005-06-01 2008-03-18 Edison Pharmaceuticals Inc Sustancias terapeuticas activas redox para el tratamiento de enfermedades mitocondriales y otras condiciones o modulacion de biomarcadores de energia.
US9278085B2 (en) 2006-02-22 2016-03-08 Edison Pharmaceuticals, Inc. Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
NO2470168T3 (en:Method) 2009-08-26 2018-06-30
JP2011178687A (ja) * 2010-02-26 2011-09-15 Kochi Univ 造血細胞移植に伴う疼痛の予防および／または治療剤
US20140099262A1 (en) 2011-06-01 2014-04-10 Brain Watch Ltd. Isotopically labeled cdp-choline and uses thereof
CN104394885B (zh) 2012-05-31 2017-06-30 学校法人近畿大学 抗癌剂所致的末梢神经障碍性疼痛的预防和/或治疗剂
CN113024369A (zh) 2015-12-17 2021-06-25 Ptc医疗公司 用于治疗氧化应急障碍的化合物
US11497795B2 (en) 2018-09-28 2022-11-15 Asahi Kasei Pharma Corporation Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5517769B2 (en:Method) * 1972-01-10 1980-05-14
US4386078A (en) * 1980-03-03 1983-05-31 The Ohio State University Research Foundation Therapeutic agents for preventing phospholipid degradation and free fatty acid proliferation
IT1207106B (it) * 1980-04-18 1989-05-17 Made Italiana Srl Ora Searle I Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale
JPS6043078B2 (ja) * 1980-10-31 1985-09-26 株式会社興人 シチジンジリン酸コリンの製法
JPS6043079B2 (ja) * 1980-12-25 1985-09-26 株式会社興人 シチジン二リン酸コリンの製造方法
JPS57108099A (en) * 1980-12-25 1982-07-05 Kohjin Co Ltd Preparation of choline cytidine diphosphate

Also Published As

Publication number Publication date
US5872108A (en) 1999-02-16
ZA961791B (en) 1996-09-10
US5801160A (en) 1998-09-01
KR19980702724A (ko) 1998-08-05
IL147477A (en) 2010-02-17

Similar Documents

Publication Publication Date Title
BR122012014331A2 (en:Method)
BRPI9612258B1 (en:Method)
BRPI9612138B1 (en:Method)
IN186066B (en:Method)
IN186075B (en:Method)
IN182555B (en:Method)
FR2729757B1 (en:Method)
CH0741373H1 (en:Method)
IN185479B (en:Method)
BR7502120U (en:Method)
BR7501503U (en:Method)
ECSDI950283S (en:Method)
AU1627395A (en:Method)
IN183534B (en:Method)
IN177927B (en:Method)
IN187590B (en:Method)
EP0741064A3 (en:Method)
CN3037189S (en:Method)
CN3029928S (en:Method)
CN3030154S (en:Method)
CN3030543S (en:Method)
CN3030197S (en:Method)
CN3030542S (en:Method)
BY5258C1 (en:Method)
CN3030225S (en:Method)